Associate Professor Cheng is a medicinal chemist and molecular and cell biologist whose research is dedicated to the early detection and improved treatment of cancer. Over the past 12 years, her work has focused on mesothelioma, a rare cancer, leading to the initiation of two clinical trials. She is one of the most successful scientists in securing mesothelioma research funding in Australia, with the majority of research grants awarded to her program. Her innovative research into miRNA has pioneered a new field in mesothelioma detection and treatment. She leads a multidisciplinary team of postdoctoral scientists, oncologists, and pathologists in conducting clinical trials that utilize novel nanocarrier she designed to enhance the tumor-suppressing effects of miRNA while minimizing side effects. In addition, A/Prof Cheng addresses critical gaps in anticancer treatment by investigating natural plant extracts and formulations. Her research has led to two significant inventions: one currently filed as a PCT application and the other honored with the HKPC patent award. With her innovative technology, she aims to further explore and refine active ingredients for cancer adjuvant therapy.
Yuen Yee Cheng
